Open AccessIt Is Time to Determine Tocilizumab’s Place in Coronavirus Disease 2019 (COVID-19)
Author(s) -
Timothée Klopfenstein,
Aurélie Gerazime,
Marc Puyraveau,
N’dri Juliette Kadiane-Oussou,
Vincent Gendrin,
Souheil Zayet
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab480
Subject(s) - covid-19 , tocilizumab , coronavirus , virology , medicine , coronavirus infections , betacoronavirus , pandemic , disease , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom